Ambea as an investment
- Growing need
- Strong market position with a Nordic platform
- High quality and competence
- Substantial growth
- Balanced risk
- Strong cash flow and stable dividend
The share
Key figures FY 2024
14,195 MSEK
Net sales
1,372 MSEK
EBITA
7%
Growth
9.7%
EBITA margin
News and press releases
Calendar
- Nov 202025-11-20 08:00Jefferies Global Healthcare Conference in London/UK
- Nov 212025-11-21 08:00Roadshow Nordea in Helsinki/Finland
- Feb 122026-02-12 06:002026-01-09 – 2026-02-12 Silent period
- Feb 122026-02-12 07:00Year-end Report 2025
Reports
Interim report January–September 2025
We are accelerating growth and creating value by meeting more people’s needs for quality care, while continuing to deliver in line with our financial targets in the third quarter.
Annual report: Future-proof care
Annual report with quality & sustainability report 2024
CEO Mark Jensen about the Interim report January-September 2025
CEO Mark Jensen presents the report from Vardaga Villa Sarvträsk outside Stockholm.
IR Contact
Susanne Vogt
Head of IR, Reporting & Group Business Control
No matching results.
